Self-operated Endo-vaginal Telemonitoring (SOET), an Economic &

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The SOET project introduces a new strategy for routine follow-up of follicle growth during the hormonal treatment phase of an in-vitro fertilization (IVF) treatment cycle. After a learning instruction and demo, patients should be able to perform most of their vaginal echoes at home. The images can be sent to the medical center over the internet. These images are analyzed by the expert.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01576744` - Serum Biomarker HE4 During IVF Treatment	N/A
Completed	`NCT03660813` - Follicle Size and Oocyte Development	N/A
Completed	`NCT00461422` - Early Follicular Supplementation of Ganirelix in IVF 2004	Phase 4

NCT number	NCT01781143
Study type	Interventional
Source	University Hospital, Ghent
Contact
Status	Completed
Phase	N/A
Start date	January 2012
Completion date	June 2017

Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF) — SOET

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms